| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $349.0M | +16.3% |
| R&D Expense | $14.9M | -21.8% |
| SG&A Expense | $64.0M | +20.4% |
| Operating Income | $7.4M | -65.1% |
| Pre-tax Income | -$16.3M | -401.4% |
| Income Tax | -$52.7M | -492.3% |
| Net Income | $36.4M | +154.2% |
| EPS (Basic) | $0.15 | +650.0% |
| EPS (Diluted) | $0.15 | +650.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.4M | +0.4% |
| Accounts Receivable | $61.8M | +93.1% |
| Current Assets | $122.7M | +4.7% |
| Total Assets | $959.5M | +8.9% |
| Current Liabilities | $104.2M | +0.6% |
| Long-term Debt | $361.3M | +17.5% |
| Total Liabilities | $461.7M | +11.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $36.5M | +10.5% |
| Capital Expenditures | $70.7M | -44.4% |
| Investing Cash Flow | -$77.3M | +42.5% |
| Financing Cash Flow | $41.6M | -50.2% |
| Free Cash Flow | -$34.2M | +63.7% |
| -$12.9M |
| +91.3% |